CalculatorGastroenterology and hepatology
NAFLD fibrosis score (NFS)
Estimates the likelihood of advanced fibrosis in non-alcoholic/metabolic fatty liver disease from routine clinical and laboratory data.
Updated 31 October 2026
When to use it
Adults with non-alcoholic fatty liver disease (MASLD) to decide who needs elastography, biopsy or hepatology referral.
What it needs
- Age
- Body mass index
- Impaired fasting glucose or diabetes
- AST
- ALT
- Platelets
- Albumin
Formula
NFS = −1.675 + 0.037 × age + 0.094 × BMI + 1.13 × (IFG or diabetes) + 0.99 × AST/ALT − 0.013 × platelets (×10⁹/L) − 0.66 × albumin (g/dL)
How to interpret it
| Result | Interpretation |
|---|---|
| < -1.455 | < −1.455: advanced fibrosis unlikely (F0–F2) |
| -1.455 to < 0.677 | −1.455 to 0.676: indeterminate; consider elastography |
| ≥ 0.677 | > 0.676: advanced fibrosis likely (F3–F4) |
Practical tip
Below −1.455 advanced fibrosis is ruled out with high negative predictive value; above 0.676 it is suggested with high positive predictive value.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
